Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Multiparametric Imaging Analysis: Magnetic Resonance Spectroscopy.

Rapalino O, Ratai EM.

Magn Reson Imaging Clin N Am. 2016 Nov;24(4):671-686. doi: 10.1016/j.mric.2016.06.001. Epub 2016 Sep 13. Review.

PMID:
27742109
2.

Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.

Huang J, Wang AM, Shetty A, Maitz AH, Yan D, Doyle D, Richey K, Park S, Pieper DR, Chen PY, Grills IS.

Magn Reson Imaging. 2011 Sep;29(7):993-1001. doi: 10.1016/j.mri.2011.04.004. Epub 2011 May 14.

PMID:
21571478
3.

Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.

Seeger A, Braun C, Skardelly M, Paulsen F, Schittenhelm J, Ernemann U, Bisdas S.

Acad Radiol. 2013 Dec;20(12):1557-65. doi: 10.1016/j.acra.2013.09.003.

PMID:
24200483
4.

Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.

Nakajima T, Kumabe T, Kanamori M, Saito R, Tashiro M, Watanabe M, Tominaga T.

Neurol Med Chir (Tokyo). 2009 Sep;49(9):394-401.

5.

Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.

Lai PH, Hsu SS, Ding SW, Ko CW, Fu JH, Weng MJ, Yeh LR, Wu MT, Liang HL, Chen CK, Pan HB.

Surg Neurol. 2007;68 Suppl 1:S25-36.

PMID:
17963918
6.

Diagnostic Value of Magnetic Resonance Spectroscopy Compared with Stereotactic Biopsy of Intra-axial Brain Lesions.

Abdelaziz O, Eshra M, Belal A, Elshafei M.

J Neurol Surg A Cent Eur Neurosurg. 2016 Jul;77(4):283-90. doi: 10.1055/s-0035-1571162. Epub 2016 Mar 2.

PMID:
26935295
7.

[Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].

Galanaud D, Nicoli F, Le Fur Y, Roche P, Confort-Gouny S, Dufour H, Ranjeva JP, Peragut JC, Viout P, Cozzone PJ.

Ann Med Interne (Paris). 2002 Dec;153(8):491-8. French.

PMID:
12610422
8.

The pattern of proton magnetic resonance spectroscopy in non-neoplastic encephalic lesions.

Faria AV, Reis F, Zanardi VA, Menezes JR, Cendes F.

Arq Neuropsiquiatr. 2004 Jun;62(2B):429-36. Epub 2004 Jul 20.

9.

Development and applications of in vivo clinical magnetic resonance spectroscopy.

Cox IJ.

Prog Biophys Mol Biol. 1996;65(1-2):45-81. Review.

PMID:
9029941
10.

Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.

Porto L, Hattingen E, Stuecher A, Herminghaus S, Lanfermann H, Ulrich Pilatus UP.

J Neurol Surg A Cent Eur Neurosurg. 2012 May;73(3):147-52. doi: 10.1055/s-0032-1313723. Epub 2012 May 3.

PMID:
22190143
11.

Role of magnetic resonance spectroscopy in evaluation of congenital/developmental brain abnormalities.

Shekdar K, Wang DJ.

Semin Ultrasound CT MR. 2011 Dec;32(6):510-38. doi: 10.1053/j.sult.2011.08.001.

PMID:
22108216
12.

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.

Rock JP, Scarpace L, Hearshen D, Gutierrez J, Fisher JL, Rosenblum M, Mikkelsen T.

Neurosurgery. 2004 May;54(5):1111-7; discussion 1117-9.

PMID:
15113465
13.
14.

Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.

Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D, Kun LE, Taylor J.

Neurosurgery. 1997 Feb;40(2):331-7; discussion 337-8. Review.

PMID:
9007866
15.

[Magnetic resonance spectroscopy in gliomas].

Galanaud D, Chinot O, Metellus P, Cozzone P.

Bull Cancer. 2005 Apr;92(4):327-31. Review. French.

16.

Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.

Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK.

AJNR Am J Neuroradiol. 1995 Sep;16(8):1593-603.

17.

Proton magnetic resonance spectroscopy: clinical applications in patients with brain lesions.

Ramin SL, Tognola WA, Spotti AR.

Sao Paulo Med J. 2003 Nov 6;121(6):254-9. Epub 2004 Jun 28. Review.

18.

Analysis of brain tumors using 1H magnetic resonance spectroscopy.

McBride DQ, Miller BL, Nikas DL, Buchthal S, Chang L, Chiang F, Booth RA.

Surg Neurol. 1995 Aug;44(2):137-44.

PMID:
7502203
19.

Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.

Lotumolo A, Caivano R, Rabasco P, Iannelli G, Villonio A, D' Antuono F, Gioioso M, Zandolino A, Macarini L, Guglielmi G, Cammarota A.

Eur J Radiol. 2015 Dec;84(12):2597-604. doi: 10.1016/j.ejrad.2015.09.005. Epub 2015 Sep 11.

PMID:
26391231
20.

Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.

Balos DR, Gavrilović S, Lavrnić S, Vasić B, Macvanski M, Damjanović D, Opinćal TS.

Vojnosanit Pregl. 2013 Jul;70(7):637-44.

PMID:
23984611

Supplemental Content

Support Center